Public Invited to Cancer Research Funding Discussions
Published Date: 1/28/2026
Notice
Summary
The National Cancer Institute is holding a public meeting on June 29-30, 2026, to discuss cancer research updates and review grant applications. Anyone interested can join in person or online, but part of the meeting will be private to protect sensitive information. This is a great chance for researchers and the public to stay in the loop about important cancer research decisions and funding.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
Public meeting: in-person and virtual
The National Cancer Advisory Board will hold a public meeting on June 29, 2026 (6:00 p.m. to 9:00 p.m.) and June 30, 2026 (9:00 a.m. to 4:00 p.m.). You can attend in person at listed Maryland locations or view the meeting online via the NIH Videocast at http://videocast.nih.gov/.
Closed session for grant review
A portion of the meeting on June 30, 2026 from 4:00 p.m. to 5:00 p.m. will be closed to the public to review and evaluate grant applications to protect confidential trade secrets, commercial property, and personal information.
On-site entry security requirements
If you plan to attend in person at the NCI-Shady Grove campus, you must show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and state the purpose of your visit due to instituted security procedures.
Opportunity to file written comments
Anyone may file written comments with the committee by sending a statement to the listed Contact Person; the statement should include your name, address, telephone number, and, if applicable, business or professional affiliation.
Accommodations for virtual viewers
If you plan to view the virtual meeting and need special assistance or other reasonable accommodations, you should notify the listed Contact Person in advance of the meeting.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2026-01694 — Information Collection Being Submitted for Review and Approval to Office of Management and Budget
The Federal Communications Commission (FCC) is asking the public and other agencies to review and comment on their paperwork rules by February 27, 2026. They want to make it easier for small businesses with fewer than 25 employees to handle these forms. This review helps reduce unnecessary paperwork and keeps the process smooth and fair for everyone involved.
Next: 2026-01701 — National Institute on Alcohol Abuse and Alcoholism; Amended Notice of Meeting
Heads up! The National Institute on Alcohol Abuse and Alcoholism changed the meeting times for their big February 5, 2026, gathering in Bethesda. The closed session now runs from 1:00 to 2:00 p.m., and the open session follows from 2:30 to 4:30 p.m. This tweak affects anyone interested in the meeting schedule but doesn’t change any funding or deadlines.